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The matrix metalloproteinases (MMPs) are a family of genetically
related hydrolytic enzymes that together have the capacity to
degrade virtually every component of the extracellular matrix
(Khokha and Denhardt, 1989; Murphy and Docherty, 1992;
Crawford and Matrisian, 1996). A role for MMPs in experimental
tumour invasion and metastasis is suggested by a variety of
evidence (Khokha et al, 1989; DeClerck et al, 1991; Alexander
and Werb, 1992; DeClerck et al, 1992; Cha et al, 1996; Imren et al,
1996). Although there is little direct evidence for MMP function in
human tumour spread under in situ conditions, MMP expression is
elevated in various human tumours relative to the normal counter-
part tissues (McDonnell et al, 1991; Muller et al, 1991, 1993; Gray
et al, 1992; Pyke et al, 1992; Assam et al, 1993; Majmudar et al,
1994; MacDougall et al, 1995; Murray et al, 1996; Johansson et al,
1997). 
In regards to prostate cancer specifically, Hamdy et al (1994)
and Festuccia et al (1996) reported elevated levels of MMP-9 (92-
kDa gelatinase B) in prostate tumour tissue relative to normal
prostate or benign prostate hyperplasia (BPH). Not all investiga-
tors have demonstrated this relationship, however. Lokeshwar et al
(1993) found higher MMP-9 expression in BPH than in prostate
cancer, but higher MMP-2 expression in tumour tissue. Stearns
and Wang (1993), Montironi et al (1995, 1996), and Still et al
(2000) also demonstrated increased MMP-2 (72-kD gelatinase A)
expression in prostate carcinoma, while Upadhyay et al (1999)
found no overall change in level of MMP-2 expression between
normal and malignant prostate tissue but a change in distribution
pattern. In contrast to the expression of these gelatinolytic
enzymes (with type IV collagenolytic activity), there is little
evidence for elaboration of enzymes which can degrade interstitial
connective tissue. Pajouh et al (1991) reported that mRNA for
MMP-1 (interstitial collagenase) was not detectable in either
normal or malignant prostate specimens. MMP-1 immunoreac-
tivity was detected in plasma of prostate cancer patients, but the
amount detected was not significantly different from amount
present in normal volunteers (Jung et al, 1997). Finally, Wilson
et al (1993) identified enzymes with caseinolytic activity (consis-
tent with the action of mammalian collagenases) in prostatic
secretions of individuals with BPH, atypia or prostate cancer.
Considerable variability was seen, and there was no clear-cut
relationship with disease-state. 
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Summary  Prostate tissue was obtained from 22 radical prostatectomies (performed for clinical management of prostate carcinoma)
immediately after surgery. A small piece of tissue was fixed immediately in formalin and used for routine histology while a second piece was
frozen in OCT and used for immuno-histochemistry. Another small piece was used for isolation of epithelial and stromal cells. The remainder
of the tissue was cut into 2 ´ 2 mm pieces and incubated in organ culture for 8 days. In organ culture, non-malignant, basal epithelial cells
underwent a proliferative response. This was accompanied by de-differentiation of glandular structures and by migration of epithelial cells
across the surface of the tissue. Erosion of the basement membrane could also be seen in places, but was not widespread. Invasion of
epithelial cells into the adjacent stroma was not evident. Production of matrix metalloproteinases (MMPs) with gelatinolytic activity or
collagenolytic activity was assessed in organ culture and compared to expression patterns in fresh tissue. MMP-1 (interstitial collagenase)
and MMP-9 (92-kDa gelatinase B) were undetectable or low in fresh tissue specimens. Both enzymes were detected in organ culture and
both increased over time. Even after 6 days, however, there was only a low level of gelatin-hydrolytic activity and no measurable collagen-
hydrolytic activity. In past studies we used organ cultures of normal skin and malignant skin tumours (basal cell carcinomas) to help elucidate
the role of collagenolytic and gelatinolytic MMPs in epithelial cell invasion (Varani et al, 2000). Compared to MMP levels observed in skin,
levels of these enzymes in prostate are low. The low level of collagenolytic and gelatinolytic MMPs in fresh prostate tissue and in organ-
cultured prostate tissue may help explain why there is little tissue destruction in many primary prostate tumours and why the majority of such
tumours remain confined to the prostate for extended periods. © 2001 Cancer Research Campaign http://www.bjcancer.com
Keywords: prostate; carcinoma; organ culture; matrix metalloproteinases; collagenase; gelatinase 
1076
Received 21 August 2000 
Revised 14 December 2000 
Accepted 19 December 2000 
Correspondence to: J Varani 
British Journal of Cancer (2001) 84(8), 1076–1083
© 2001 Cancer Research Campaign
doi: 10.1054/ bjoc.2000.1712, available online at http://www.idealibrary.com on  http://www.bjcancer.comMMPs in prostate 1077
British Journal of Cancer (2001) 84(8), 1076–1083 © 2001 Cancer Research Campaign
Although these past studies clearly indicate that several MMPs
are elaborated in prostate tumours and suggest differences
between malignant and non-malignant tissue, the heterogeneity in
prostate tumour presentation and the variability in the analytical
methods used make elucidating the relationship between enzyme
elaboration and disease-state difficult to ascertain. Furthermore,
the presence of active forms of the enzymes has not been estab-
lished in these studies, and the biological significance of the
reported differences is unclear. In the present study, a combination
of approaches has been employed to assess expression of
collagenolytic and gelatinolytic MMPs in prostate tissue removed
for treatment of prostate carcinoma. We report here that gelati-
nolytic and collagenolytic MMPs can be detected in freshly
isolated prostate tissue or in short-term (2–3 day) organ culture.
Expression is heterogeneous from tissue to tissue, consistent with
the variation in disease presentation. Expression patterns in fresh
tissue and organ-cultured tissue also differ. Enzyme levels
measured in vitro appear to primarily reflect production by non-
malignant components rather than malignant cells. Perhaps most
interesting, overall levels of the collagenolytic and gelatinoltyic
MMPs are low in prostate tissue relative to other tumours (for
example, basal cell carcinomas of skin) that have been examined
in the past with the same approaches (Varani et al, 2000). The lack
of tissue destruction and the relatively low invasive potential of
the majority of prostate tumours may be reflective of this. 
MATERIALS AND METHODS 
Tissue source 
Human prostate tissue was obtained from 22 radical prostatec-
tomies immediately after surgery. In all cases, a diagnosis of
prostate carcinoma had been previously made based on a 6 needle
biopsy protocol, and in all cases there was no evidence of tumour
spread beyond the prostate at the time of surgery. 5 of the tumours
were classified as Gleason grades 4 or 5; 13 were classified as
Gleason grade 6 or 7; and the remaining 4 were of higher grades
(grades 8–10). The percentage of the tumour component within the
tissue ranged from 1–90%. Routinely, we were able to obtain 1–2
cm3 of tissue from areas of the prostate in which tumour was
present. In addition, areas of the prostate in which no tumour was
identified histologically were also available in most cases. Prostate
intra-epithelial neoplasm (PIN) and/or BPH were present in some
of these tissue specimens. Upon arrival in the laboratory, a small
piece from each specimen was fixed in 10% buffered formalin,
stained with haematoxylin and eosin and evaluated for amount of
tumour present and histological features of the tumour. A second
tissue piece was frozen in OCT immediately after surgery and used
for immunostaining. Additional tissue pieces were used for the
isolation of epithelial cells and stromal (fibroblast-like) cells in
monolayer culture (see below) and the remainder was incubated in
organ culture (see below). 
MMP immunohistology 
Tissue frozen in OCT was examined by immunoperoxidase
staining for MMP-1, MMP-2, MMP-9 and MMP-13 expression as
described previously (Varani et al, 2000). Briefly, frozen sections
were mounted on glass slides coated with poly-L-lysine and
stained using the ABC method (Vector Labs; Burlingame, CA).
Diaminobenzidine was used as the chromogenic substrate, and
tissue were counterstained with haematoxylin. A rabbit polyclonal
IgG antibody to MMP-1 was obtained from Chemicon (Temecula,
CA). Monoclonal antibodies to MMP-2, MMP-9 and MMP-13
were obtained from Oncogene Sciences (Cambridge, MA).
Antibody specificity was established based on reactivity with puri-
fied MMPs in Western blots, reactivity with appropriately sized
moieties in organ culture fluids and a lack of reactivity with other
sized moieties in the same culture fluids (Varani et al, 2000). A
mouse monoclonal IgG1 antibody (Oncogene Sciences) and a
rabbit polyclonal IgG antibody (R & D Systems, Minneapolis,
MN) were used as controls. 
Organ culture procedures and assessment 
Tissue for organ culture was cut into pieces approximately 1.5–
2 mm in size and incubated in wells of a 24-well dish; each well
contained 5–6 tissue pieces in 0.5 ml of culture medium. The
culture medium was Keratinocyte Growth Medium (KGM)
(Clonetics, Inc, Walkersville, MD). KGM is a serum-free modifi-
cation of MCDB-153 medium, supplemented with a combination
of growth-promoting agents including epidermal growth factor
(0.1 ng ml–1), insulin (0.5 mgm l –1) and pituitary extract (2%). It
was further supplemented with CaCl2 to bring the final Ca2+
concentration to 1.4 mM and with 800 ng ml–1 dihydrotestosterone
(DHT). Cultures were incubated at 37˚C in an atmosphere
containing 5% CO2 and 95% air. Fresh culture medium was
provided at 2–3 day intervals. 
At the end of the incubation period (day 8), tissue pieces were
fixed in 10% buffered formalin and stained with haematoxylin and
eosin. Histological features were compared to those seen at time-
zero. Sections from the same tissue pieces were also stained with
an anti-cytokeratin antibody (K903), from Boehringer Mannheim
Biochemicals (Indianapolis IN). This antibody recognizes high
molecular weight keratins expressed by normal basal epithelial
cells in the prostate but not expressed in prostate carcinoma cells
(Makin et al, 1984). Additional sections were stained with an anti-
body to the proliferation-associated antigen, Ki-67 (Key et al,
1993). This antibody (MIB-1) was obtained from Immunotech
(Westbrook, ME). Ki-67 staining was used to confirm that epithe-
lial cell expansion did, in fact, reflect a proliferative response.
Finally, sections were stained by the Periodic Acid-Schiff (PAS)
method and used for basement membrane evaluation. The
percentage of the gland surrounded by PAS-positive material was
estimated and scored as 0, 0.25, 0.5, 0.75 or 1.0, where 0 indicates
a complete lack of PAS-positive material around the gland and 1.0
indicates a complete encompassing of the gland with PAS-reactive
material. Some sections were also stained with PAS-methenamine
silver to confirm PAS results. PAS-methenamine silver is more
specific for basement membrane, although cellular architecture is
lost (Varani et al, 1999). 
Used organ culture fluid was collected at each media change
and analysed for MMP-1, MMP-2, MMP-9 and MMP-13 by a
combination of zymography, Western blotting and specific
substrate degradation assays (see below). 
Isolation of cells from prostate tissue 
Prostate epithelial cells and stromal cells were isolated and charac-
terized as described in a recent report (Varani et al, 1999). Epithelial
cells were defined on the basis of cobblestone morphology. Normal1078 J Varani et al 
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basal epithelial cells and malignant epithelial cells were distin-
guished on the basis of reactivity with anti-keratin antibody K903
(Makin et al, 1984). Virtually all of the epithelial cells that grew in
monolayer culture were strongly positive (indicative of normal basal
cells). Stromal cells were identified on the basis of spindle-shape
and a lack of staining with keratin antibodies. Of the stromal cells
isolated, approximately 5–10% were identified as smooth muscle
cells on the basis of reactivity with desmin and smooth muscle 
a-actin and 10–15% were identified as myofibroblasts on the basis
of reactivity with smooth muscle a-actin but not desmin. Occasional
cells (<1%) stained with antibody to von Willibrand factor and were
identified as endothelial cells. The remaining cells stained with none
of these markers and were identified as fibroblasts. 
Substrate-embedded enzymography 
SDS-PAGE substrate-embedded enzymography (zymography)
was used to identify enzymes with collagenase and gelatinase
activities. Assays were carried out exactly as described in a
previous report (Gibbs et al, 1999). Briefly, denatured but non-
reduced culture fluid samples were resolved in 7.5% SDS-PAGE
gels prepared with the added incorporation of gelatin (1 mg ml–1)
or b-casein (1 mg ml–1) prior to casting. After electrophoresis, gels
were washed twice for 15 min in 50 mM Tris buffer containing
1 mM Ca2+ and 0.5 mM Zn2+ with 2.5% Triton X-100. The gels
were then incubated overnight in Tris buffer with 1% Triton X-100
and stained the following day with Coumassie Brilliant Blue
250-R. Following destaining, zones of enzyme activity were
detected as regions of negative staining against the dark back-
ground. Volumes of 5–35 ml of undiluted specimen were normally
used for these assays; zones of activity were proportional to the
quantity of culture fluid used. 
Western blotting 
Culture fluid proteins were resolved by SDS-PAGE and trans-
ferred to nitrocellulose filters. Following treatment of filters with
specific antibodies, the filters were reacted with horseradish
peroxidase (HRP)-conjugated secondary antibodies. Reactive
proteins were detected by enhanced chemiluminescence (ECL,
Amersham) after treatment with luminol and visualization on
light-sensitive autoradiography film (Fisher et al, 1996). 
Gelatin and collagen degradation assays 
Acid-solubilized (rat tail) fibrillar type I collagen was obtained
from Becton-Dickinson (Bedford, MA). Native collagen and heat-
denatured (60˚C 5 min) collagen (i.e., gelatin) were diluted to
1 mg ml–1 in phosphate-buffered saline (PBS, pH 7.2), and incu-
bated at 37˚C for 18 hours with prostate organ culture fluids which
had previously been concentrated 10X. Prior to the addition of the
collagen or gelatin substrates, culture fluids were exposed to 1 mM
aminophenyl mercuric acetate (APMA) for 90 min to activate
latent enzyme (Gibbs et al, 1999). Substrates not exposed to organ
culture fluids and culture fluids without substrates were incubated
in parallel as negative controls. At the end of the 18-hour incuba-
tion period, samples were resolved by SDS-PAGE. The presence
of active enzyme was determined, based on the disappearance of
the parental a1(I) and a2(I) collagen (or gelatin) bands and the
appearance of lower molecular weight fragments (Mulligan et al,
1993; Varani et al, 2000). 
MMP-2
MMP-9
MMP-13
Figure 1 MMP expression in prostate tissue immediately following surgery.
Tissue frozen in OCT was incubated with monoclonal antibodies to each of
the 3 MMPs followed by incubation with an immunoperoxidase-conjugated
secondary antibody. Diaminobenzidine was used as chromogen and
haematoxylin was used as counterstain. (Magnification: MMP-2, 3160;
MMP-9, 3400; MMP-13; 3160) RESULTS 
MMP expression in human prostate tumour tissue
immediately after surgery 
Immunoperoxidase staining was used to determine expression of
enzymes with gelatinolytic activity (i.e., MMP-2 and MMP-9) in
22 different human prostate tumour specimens immediately after
surgery. In 9 of the specimens, regardless of whether or not tumour
was present or the amount present, there was little or no detectable
staining for MMP-2. MMP-2 reactivity was observed in the
remainder of the specimens. MMP-2 reactivity was visible
throughout the stroma in the majority of these specimens (Figure
1, upper panel). In some specimens, reactivity was also observed
in a small number of normal or abnormal glandular epithelial cells.
Routinely, however, epithelial cells were negative for MMP-2
reactivity. 
MMP-9 immunoreactivity was also weak or undetectable in
many of the specimens (11 of 22). In other specimens, staining
with anti-MMP-9 revealed the presence of antigen in either or both
stroma and epithelial structures. The most intense staining with
anti-MMP-9 occurred in the epithelial cells of highly anaplastic
lesions, where glandular structures were disorganized (Figure 1,
middle panel). 
Tissue sections from the same specimens were also stained with
antibodies to MMP-1 (interstitial collagenase) and MMP-13
(collagenase 3). With the exception of an occasionally positive
stromal cell, no staining with antibody to MMP-1 was observed in
any of the specimens (not shown). In contrast, staining with anti-
MMP-13 was seen in virtually every specimen. Staining was
confined to vascular structures as shown in the lower panel of
Figure 1. Overall, there was no clear distinction in MMP-13
immunoreactivity between tissue sections in which extensive
tumour was present and sections in which there was little or no
evidence of tumour. 
Human prostate tissue in organ culture: histological
features 
Tissue pieces from each surgical specimen were incubated in
organ culture as described in the Materials and Methods section.
After 8 days, the tissue was fixed in 10% buffered formalin and
evaluated histologically. Consistent with what we have reported
previously (Varani et al, 1999), there was a loss of secretory
epithelial cells and replacement of the normal glandular structure
with morphologically undifferentiated (basal) epithelial cells. In
some places, basal epithelial cells filled the lumens of the glands,
obliterating normal architectural features. In addition to occupying
the glands, epithelial cells also grew out from the glands to cover
the surface of the tissue. Figure 2A shows the typical appearance
of haematoxylin and eosin-stained tissue on day 8. Staining with
antibody to Ki-67 confirmed a proliferative response in the epithe-
lial cell population (Figure 2B). Staining with the anti-keratin anti-
body, K903, revealed strong reactivity in virtually all of the
hyper-proliferative glands, as well as in the cells which migrated
out from the glands (Figure 2C). Reactivity of the proliferating
cells with this antibody, which is known to react with basal epithe-
lial cells but not with malignant cells (Makin et al, 1984), indicates
that the proliferating cells were derived from the non-malignant
epithelial cell component present in the original tissue. Consistent
with what we have reported in the past (Varani et al, 1999), the vast
majority of histologically abnormal, K903-negative cells (presum-
ably tumour) were lost from the tissue after 8 days in organ culture
under the conditions employed here. 
Figure 2D and 2E show the appearance of the tissue after
staining by the PAS method. Consistent with the picture shown in
MMPs in prostate 1079
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Figure 2 Histological appearance of human prostate tissue after 8 days in organ culture. (A) Haematoxylin and eosin-stained section showing glandular
structures in which secretory cells have disappeared and basal epithelial cells have filled in the lumens of the glands. Epithelial cells also cover the surface of
the tissue piece. (B) Ki-67-stained section demonstrating proliferation in many of the epithelial cells. (C) K903-stained section showing strong reactivity in the
hyper-proliferative glands and in cells that have migrated out of these glands. (D) PAS-stained section showing an epithelial structure surrounded by distinct
PAS-positive (basement membrane) material. (E) PAS-stained section showing epithelial cells not surrounded by distinct PAS-positive (basement membrane)
material 1080 J Varani et al 
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Figure 2D, most of the hyper-proliferative glands were surrounded
by PAS-reactive material (basement membrane). However, in
certain of the glands (Figure 2E), there were areas in which PAS-
reactivity was not evident. Based on a semi-quantitative assess-
ment of 77 separate glands from 9 different tissue specimens (after 8
days in organ culture), the fraction of the glandular periphery that
was clearly delineated from the surrounding stroma by PAS-positive
material was 0.8 ± 0.15% (compared to approximately 0.9 ± 0.10 in
fresh tissue; not statistically different at P < 0.05 level). Selected
specimens were also stained with PAS-methenamine silver, which is
a more specific basement membrane stain (Varani et al, 1999). 
PAS-staining and staining with PAS-methenamine silver occurred
in parallel (not shown). 
MMP expression in human prostate tissue in organ
culture 
Prostate tissue was incubated in organ culture for 8 days. Culture
fluids were collected on days 2, 4 and 6, and assessed for MMP-2
and MMP-9 by gelatin zymography. Zones of activity corre-
sponding to both enzymes were seen at all 3 time points. The level
of MMP-2 remained constant throughout the 6-day culture period
(Figure 3A). In contrast, the level of MMP-9 was low initially, but
increased as a function of time in culture (Figure 3A). With both
enzymes, the higher molecular weight, latent, proenzyme forms
predominated. Lower molecular weight forms, characteristic of
active enzymes, were detectable in most cases, but these forms
were present as thin ‘shadow’ bands immediately below the parent
enzyme bands, and constituted a small fraction of the total. 
The same culture fluids were analysed for b-caseinolytic activity.
Activity was detected as a doublet in the 54 kD region of the gel
(indicative of the proform of MMP-1). Essentially no activity was
seen in the 45 kD region of the gel (corresponding to active form of
the enzyme). As can be seen in Figure 3B, there was little activity in
day 2 organ culture fluids, with progressively increased amounts on
day 4 and day 6. The b-caseinolytic activity in the prostate organ
culture fluids was due mainly to MMP-1 based on the following
information: i) activity was completely abolished by overnight incu-
bation of the zymogram in buffer containing 10 mM EDTA (metallo-
proteinase inhibitor) but was unaffected by the presence of 2 mM
phenyl methyl sulphonylfluoride (serine proteinase inhibitor) in the
buffer; ii) upon exposure of the culture fluid to APMA, an agent used
routinely as an MMP activator (Gibbs et al, 1999), a ‘band-shift’ to
45 kD occurred; iii) b-caseinolytic activity in the prostate organ
culture fluid co-migrated with a zone of b-caseinolytic activity
produced by human dermal fibroblast MMP-1; and iv) Western blot-
ting revealed the presence of an anti-MMP-1-reactive moiety in
prostate organ culture fluids that co-migrated with the
b-caseinolytic activity (data not shown). In contrast, no reactivity
with an antibody to MMP-13 was detected by Western blotting in the
same specimens. In addition to the b-caseinolytic activity observed in
the 54 kD region of the gel, a thin band of activity was also detected
in the higher molecular weight region (Figure 3B). This activity co-
migrated with human dermal fibroblast MMP-2. No other zones of
activity were detected. 
Organ culture fluids were obtained from prostate tissues after incu-
bation for 72 hours and concentrated 10-fold. Gelatin and collagen
degradation assays were carried out using the concentrated culture
fluid. A low level of gelatin fragmentation was detected in these
culture fluids, while fragmentation of intact fibrillar collagen was not
evident with either non-activated culture fluids or following exposure
to 1 mM APMA (Figure 4). Organ culture fluids collected on day 6
(72-hour culture fluids) and handled the same way also were devoid
of detectable collagenolytic activity (not shown). 
In a final set of studies, epithelial cells and stromal cells were
grown for 2 days in monolayer culture. Cell culture fluids obtained at
the end of the incubation period were examined by gelatin and b-
casein zymography. Epithelial cells produced gelatinolytic activities
corresponding to both MMP-2 and MMP-9 while stromal fibroblast-
like cells elaborated only MMP-2. Both cell types also produced a 54
kD b-caseinolytic activity. The level of b-caseinolytic activity was
higher in the culture fluid from epithelial cells than in the stromal cell
culture fluid. There was no evidence of a higher molecular weight
activity that would be consistent with MMP-13 in the culture fluid
from either cell type (not shown). 
54kD
92kD
72kD
Day 4 Day 2 Day 6 Day 2 Day 4 Day 6
Gelatin A. Casein B.
Figure 3 Gelatinolytic and b- caseinolytic activity assessed by zymography in 48-hour prostate organ culture fluids obtained after 2, 4 or 6 days in culture. (A)
Gelatin: Pro-MMP-2 (latent form) is represented by the major band at 72 kDa. The shadow band immediately beneath the major band represents a processed
(active) form of the enzyme. MMP-2 remains consistent over the 6-day period. Pro-MMP-9 (latent form) is represented by the major band at 92 kDa. The
shadow band immediately beneath the major band represents a processed (active) form of the enzyme. MMP-9 increases over the 6-day period. (B) b-casein:
Pro-MMP-1 is represented by a doublet in the 54–57 kDa region of the gel. There are no lower molecular weight forms attributable to the active form of the
enzyme. MMP-1 increases over the 6-day period MMPs in prostate 1081
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DISCUSSION 
In the present study we have assessed the expression of MMPs
with collagenolytic and gelatinolytic activity in fresh prostate
tumour specimens and in organ cultures established from the same
specimens. The results are discussed in relation to a number of
issues including: i) the variability among different specimens, and
the variability seen with different methods of assay; ii) alterations
that occur in prostate tissue structure/function over time in organ
culture, the overall levels of collagenolytic and gelatinolytic
enzymes elaborated in organ culture, and the possible role of
MMPs in these alterations; and iii) the implication of the findings
for prostate tumour pathophysiology. 
Considerable variability in MMP expression was observed among
the 22 specimens analysed. In approximately half of the fresh tissues,
MMP-2 and/or MMP-9 were not clearly identifyable by immunos-
taining. Except for an occasional reactive cell, MMP-1 was never
routinely detected in this way, while MMP-13 was detected in the
vasculature of virtually every specimen. In short-term (2–3 day)
organ culture, MMP-1, as well as MMP-2 and MMP-9, was detected,
but MMP-13 was not. Variability among specimens was due, in part
we believe, to the heterogeneity in prostate tumour presentation, and
to the amount of tumour present in any given tissue piece, as well as
to intrinsic differences among tumours in enzyme elaboration. Some
of the tumours demonstrated relatively well-differentiated features
(Gleason scores of 4 or 5) while at the other extreme were tissues
with highly anaplastic features. Equally important, the estimated
percentage of the tissue occupied by tumour ranged from 1% to
greater than 90%. Given this heterogeneity in the starting material, it
is not surprising that there should be differences in MMP detection. 
Although heterogeneity in prostate tumour presentation undoubt-
edly accounts for some of the variability noted, differences in analyt-
ical approaches also contribute to the variable results. It is clear from
this work that even after incubation for as little as 2–3 days in organ
culture, the culture medium from virtually every specimen contained
detectable MMP-1, MMP-2 and MMP-9 as measured by zymog-
raphy and Western blotting. These analytical techniques, particularly
zymography are extremely sensitive (down to picogram quantities)
(Gibbs et al, 1999) so it may be that enhanced enzyme detection
reflects the increased sensitivity of the procedures used.
Alternatively, differences in enzyme expression patterns between
fresh tissue and organ-cultured tissue may reflect physiological
differences. Consistent with our past report (Varani et al, 1999),
normal basal epithelial cells underwent a proliferative response in
organ culture under the conditions employed here while the majority
of tumour cells lysed under the same conditions. The differences in
enzyme recovery between fresh tissue specimens and short-term
organ culture may, therefore, reflect a loss of malignant cells and a
concomitant up-regulation of MMP production in association with
the proliferative response in the normal component. The same
signalling events that lead to epithelial cell proliferation also induce
MMP production via AP-1 activation (Zeigler et al, 1999). Some of
the variability in previously published reports (Lokeshwar
et al, 1993; Stearns and Wang, 1993; Wilson et al, 1993; Hamdy et al,
1994; Montironi et al, 1995, 1996; Festuccia et al, 1996; Jung
et al, 1997; Upadhyay et al, 1999; Still et al, 2000) may also have a
similar basis. It should be noted that although we attribute the
increase in MMP expression in organ culture primarily to the action
of proliferating basal (non-malignant) epithelial cells, the presence of
‘occult’ tumour in the tissue cannot be completely ruled out. The
presence of occult tumour would also be expected to contribute to the
MMP levels observed in organ culture. 
Two other issues need to be addressed. The first is the potential
relationship between the MMPs elaborated by prostate tissue in
organ culture and the changes in tissue structure/function which
occur during organ culture. Although we were able to detect
MMP-1 as well as MMP-2 and MMP-9 in organ culture fluid, and
although the levels of MMP-1 and MMP-9 increased over time in
culture, the actual amounts of all 3 enzymes in the tissue were, in
fact, very low. This can be seen by the lack of active forms of the
enzymes. Only faint, thin bands corresponding to active forms of
both MMP-9 and MMP-2 were detected in gelatin zymograms
while active forms of MMP-1 were completely undetectable in 
b-casein zymograms. Consistent with this, there was minimal
Figure 4 Gelatinolytic and collagenolytic activity assessed by substrate-
degradation assays in 72-hour prostate organ culture fluids. Intact gelatin
and intact collagen are represented by the presence of intact a1(I) and a2(I)
chains and the absence of lower molecular weight fragments. In the
presence of 103-concentrated and APMA-activated prostate organ culture
fluid, there is degradation of gelatin as indicated by the presence of lower
molecular weight bands. Such bands are not observed when collagen is
exposed to the same culture fluid 
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gelatin degradation and no detectable collagen degradation in
specific substrate assays. 
The low level of enzyme activity in organ culture may be of
interest in light of the changes that occurred in prostate tissue over
time in culture. These included a proliferative response in the basal
epithelial cell population and a concomitant loss of the malignant
component (Schrodt and Foreman, 1971; Geller et al, 1992;
Nevalainen et al, 1993; Pretlow et al, 1995; Varani et al, 1999; as
well as the present report). The present study also demonstrated
migration of the proliferating epithelial cells out from the gland
across the surface of the tissue. This occurred wherever a cut in the
tissue placed glandular epithelial cells in contact with the stroma.
Basal cells, identified by their intense staining with anti-keratin
(K903) antibody, could be seen covering the entire surface of the
tissue pieces by day 8. Keratin-positive cells could also be seen
wherever a break within the tissue was observed (Figure 2A, C). In
spite of these changes, there was little evidence for stromal inva-
sion. Basement membrane erosion (noted as a loss of staining with
PAS or PAS-methenamine silver) was observed around some of
the glands, but this was not a prominent feature in any of the
tissues and (when assessed semi-quantitatively) not statistically
different from what was observed in fresh tissue specimens.
Additionally, detailed examination of sections from organ-cultured
tissue failed to demonstrate areas in which actual epithelial cell
penetration of the stroma had occurred. 
In regard to these invasion-related events, the features observed in
prostate organ culture are significantly different from what we have
reported previously in organ cultures of normal human skin.
Exposure of organ-cultured skin to the same peptide growth factors
used here resulted in a dramatic increase in MMP production. In
parallel, damage to the dermo-epidermal basement membrane
occurred over a wide area, and epithelial cells penetrated deep into
the stroma as columns of cells and as single cells. Basement
membrane damage and stromal invasion were both inhibited by
treatment with MMP inhibitors. Although these events occurred in
the normal epidermal keratinocyte population, they provide a unique
insight into the relationship between MMP up-regulation and
stromal invasion under in situ conditions (Fligiel and Varani, 1993;
Varani et al, 1995; Zeigler et al, 1996; Chi et al, 1998). In a subse-
quent study, it was shown that the phenotype expressed in normal
skin following exposure to growth factors was indistinguishable
from that expressed endogenously in basal cell carcinoma tissue
(Varani et al, 2000). Based on comparison with these previous find-
ings in skin, the results presented here allow us to speculate that the
low level of MMP production in prostate tumour tissue contributes,
at least in part, to the lack of tissue destruction and invasion in
prostate organ culture. One might speculate further that the lack of a
dense fibrous stroma in the prostate and the lack of significant
collagenolytic enzyme activity are developmentally related. 
In a similar manner, we can suggest that the relative lack of tissue
destruction and stromal invasion in prostate carcinoma in situ may
be attributable, at least in part, to the dearth of MMP activity in
prostate tumour tissue. In other tumours, where these enzymes are
elaborated in large amounts (for example, in basal cell tumours of
skin), tissue destruction and stromal invasion are prominent features
(Bauer et al, 1997; Goslen and Bauer, 1986). Thus, the fundamen-
tally different behaviour of prostate tumours as compared to carci-
nomas of skin may be due, at least in part, to the low level of
tissue-destructive enzymes in the prostate. This is not to imply, of
course, that prostate carcinomas are completely non-invasive or
destructive. As with all malignant tumours there is some level of
tissue destruction and invasion. MMPs elaborated during the devel-
opment of the disease (although in small amount as compared to
some other tumours) may contribute to the disease process. Even
without significant amounts of enzymes capable of degrading inter-
stitial stroma, the gelatinases (MMP-2 and MMP-9) have the
capacity to degrade basement membrane (type IV) collagen
(Muschel et al, 1985), and elevated expression has been linked to
malignant behaviour in other human tumours (Pyke et al, 1992). 
In summary, a variety of approaches were used in this study to
assess elaboration of gelatinolytic and collagenolytic MMPs by
human prostate tumour tissue. There are 2 major findings from this
work. First, results obtained with fresh tissue and with organ-
cultured prostate are different. This can be attributed, at least in part,
to the fact that the normal epithelial cell component proliferates in
organ culture and is likely responsible for increased enzyme elabo-
ration. Second, the overall levels of gelatinolytic and collagenolytic
activities are low in prostate tumour tissue. This may explain, in
part, the lack of tissue destruction and the failure of many prostate
tumours to aggressively invade the surrounding stroma.
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